【摘要】 肺炎支原体肺炎（Mycoplasma pneumoniae pneumonia,MPP）临床涉及诸多方面，尤其是病原学诊断、抗菌药物的合理应用、难治性MPP的诊治以及MPP的预后和远期管理等问题，其已成为临床实践和研究的热点。中西医结合疗法在MPP急性期的治疗及早期干预、改善预后等方面的优势正逐步显现，为规范MPP中西医结合的诊治，国内该领域的部分中西医专家，结合近几年进展和循证证据对《儿童肺炎支原体肺炎中西医结合诊治专家共识（2017年）》进行全面再修订，以期更好地解决MPP诊疗中的临床问题并推动中西医结合的进展。更多还原

【Abstract】 Mycoplasma pneumoniae pneumonia(MPP) involves many aspects in clinical practice,especially in pathogen diagnosis,rational use of antibiotics,diagnosis and treatment of refractory MPP,as well as the prognosis and long-term management of MPP. It has become a hot topic in clinical practice and research. The advantages of integrated traditional Chinese and western medicine in the treatment,early intervention,and improvement of prognosis of MPP in the acute phase are gradually emerging. In order to standardize the diagnosis and treatment of MPP,some domestic experts in this field,combining recent progress and evidence-based evidence,have comprehensively revised the Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Mycoplasma Pneumoniae Pneumonia in Children(2017),In order to better solve clinical problems in the diagnosis and treatment of MPP and promote the progress of integrated traditional Chinese and western medicine.更多还原